Heart Attack and Unstable Angina

References

Citations

1. Gupta M, et al. (2002). Presenting complaint among patients with myocardial infarction who present to an urban, public hospital emergency department. Annals of Emergency Medicine, 40(2): 180–186.

2. Nissen SE, et al. (2005). Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. New England Journal of Medicine, 352(1): 29–38.

3. Ridker PM, et al. (2005). C-reactive protein levels and outcomes after statin therapy. New England Journal of Medicine, 352(1): 20–28.

4. Klocke FJ, et al. (2003). ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 108(11): 1404–1418. Available online: http://circ.ahajournals.org/content/vol108/issue11/index.shtml.

5. Grines CL, et al. (2003). Fibrinolytic therapy: Is it a treatment of the past? Circulation, 107(20): 2538–2542.

6. American College of Cardiology (ACC) and American Heart Association (AHA) (2002). Guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction. Report of the ACC/AHA Task Force on Practice Guidelines. Available online: http://www.acc.org/clinical/topic/topic.htm#guidelines.

7. McPherson R, et al. (2006). Canadian Cardiovascular Society position statement—Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Canadian Journal of Cardiology, 22(11): 913–927.

8. Heart Protection Study Collaborative Group (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet, 360(9326): 7–22.

9. Rea TD, et al. (2002). Smoking status and risk for recurrent coronary events after myocardial infarction. Annals of Internal Medicine, 137(6): 494–500.

10. Silagy C, et al. (2006). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

11. American College of Cardiology and American Heart Association (2002). ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. Summary article. Report of the ACC/AHA Task Force on Practice Guidelines. Available online: http://www.acc.org/clinical/guidelines/pacemaker/pacemaker.pdf.

12. Grundy S, et al. (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (NIH Publication No. 02–5215). Bethesda, MD: National Institutes of Health. Also available online: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf.

13. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators (2006). Homocysteine lowering with folic acid and B vitamins in vascular disease. New England Journal of Medicine, 354.

14. Bonaa KH, et al. (2006). Homocysteine lowering and cardiovascular events after acute myocardial infarction. New England Journal of Medicine, 354.

15. Rossouw JE, et al. (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA, 297(13): 1465–1477.

16. Gami A (2006). Secondary prevention of ischaemic cardiac events, search date July 2004. Online version of Clinical Evidence (15): 1–31.

17. Selvin E, et al. (2004). Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Annals of Internal Medicine, 141(6): 421–431.

18. Canadian Diabetes Association (2003). Targets for glycemic control. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes, 27(2, Suppl): S18–S20.

19. De Lorgeril M, et al. (2002). Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation, 106(12): 1465–1469.

20. Mukamal KJ, et al. (2006). Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Archives of Internal Medicine, 166(19): 2145–2150.

21. Goldberg IJ, et al. (2001). Wine and your heart: A science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation, 103(3): 472–475.

22. Berkman LF, et al. (2003). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA, 289(23): 3106–3116.

23. Aronson D, Rayfield EJ (2002). Diabetes. In EJ Topol, ed., Textbook of Cardiovascular Medicine, 2nd ed., pp. 139–170. Philadelphia: Lippincott Williams and Wilkins.

24. Natarajan MK, Yusuf S (2003). Primary angioplasty for ST-segment elevation myocardial infarction: Ready for prime time? Canadian Medical Association Journal, 169(1): 32–35.

25. Ghali WA, et al. (2003). Rising to the challenge: Transforming the treatment of ST-segment elevation myocardial infarction. Canadian Medical Association Journal, 169(1): 35–37.

26. Shrive FM, et al. (2005). Economic evaluation of sirolimus-eluting stents. Canadian Medical Association Journal, 172(3): 345–351.

27. Lange H, et al. (2004). Folate therapy and in-stent restenosis after coronary stenting. New England Journal of Medicine, 350(26): 2673–2681.

Other Works Consulted

• Joint European Society of Cardiology and the American College of Cardiology Committee (2000). Myocardial infarction redefined: A consensus document. Journal of the American College of Cardiology, 36(3): 959–969.

• American Heart Association and American College of Cardiology (2006). AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation, 113(19): 2363–2372. [Erratum in Circulation, 113(22): 847.]

• Kloner RA, et al. (2003). Cardiovascular Trials Review, 8th ed. Darien, CT: Le Jacq Communications.

Go to previous section	Go to top of page	Go to next section
Author:	Robin Parks, MS	Last Updated: February 26, 2008
Medical Review:	Caroline S. Rhoads, MD - Internal Medicine Stephen Fort, MD, MRCP, FRCPC - Interventional Cardiology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.